Weekly Analysts’ Ratings Changes for Waystar (WAY)

Several analysts have recently updated their ratings and price targets for Waystar (NASDAQ: WAY):

• 9/16/2026 – Waystar had its “equal weight” rating reaffirmed by Morgan Stanley. They now have a $28.00 price target on the stock.
• 9/15/2026 – Waystar had its “outperform” rating reaffirmed by Royal Bank Of Canada.
• 9/15/2026 – Waystar was downgraded by Barclays PLC from “overweight” to “equal weight”. They now have a $30.00 price target on the stock, up from $27.00.
• 9/3/2026 – Waystar was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 8/31/2026 – Waystar had its price target raised by Canaccord Genuity Group Inc. from $30.00 to $33.00. They now have a “buy” rating on the stock.
• 8/27/2026 – Waystar had its “outperform” rating reaffirmed by BMO Capital Markets.
• 8/27/2026 – Waystar had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $44.00 price target on the stock.
• 8/26/2026 – Waystar had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $33.00 price target on the stock.
• 8/13/2026 – Waystar had its price target lowered by Truist Financial Corporation from $38.00 to $33.00. They now have a “buy” rating on the stock.
• 8/13/2026 – Waystar was upgraded by Wolfe Research to “outperform”.
• 8/7/2026 – Waystar had its price target raised by Barclays PLC from $25.00 to $27.00. They now have an “overweight” rating on the stock.
• 7/31/2026 – Waystar had its “overweight” rating reaffirmed by KeyCorp.
• 7/31/2026 – Waystar had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $39.00 price target on the stock.
• 7/30/2026 – Waystar had its price target lowered by UBS Group AG from $37.00 to $33.00. They now have a “buy” rating on the stock.
• 7/30/2026 – Waystar had its price target lowered by Wells Fargo & Company from $36.00 to $33.00. They now have an “overweight” rating on the stock.
• 7/30/2026 – Waystar had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $33.00 price target on the stock.

Insider Activity at Waystar

In related news, CEO Matthew Hawkins sold 82,500 shares of the stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $25.97, for a total transaction of $2,142,525.00. Following the completion of the sale, the chief executive officer owned 1,804,794 shares in the company, valued at $46,870,500.18. This trade represents a 4.37% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 165,000 shares of company stock valued at $4,206,524. 3.50% of the stock is currently owned by insiders.

Waystar Holding Corp. is a healthcare payments technology company that provides cloud-based software for managing administrative and financial processes across the healthcare system. Its platform connects healthcare providers, health plans and patients, helping organizations simplify complex transactions and improve the efficiency of the revenue cycle.

The company’s products and services include patient eligibility and coverage verification, claims management and submission, payment processing, prior authorization, denial and appeal management, patient billing, and related workflow automation.